Graves Disease
TSH, Free T4, Free T3, and TSH Receptor Antibodies to help assess Graves' disease.
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
TRAb antibodies are associated with Graves' disease and may affect thyroid function. For women, these antibodies are especially relevant during pregnancy planning, as they can cross the placenta. Understanding your TRAb status may support informed reproductive health decisions.
This test measures antibodies that bind to the TSH receptor on thyroid cells. These may include stimulating antibodies that cause overactive thyroid function or blocking antibodies that may reduce thyroid activity. TRAb testing is commonly used by healthcare providers to evaluate and monitor autoimmune thyroid disease.
For women, TRAb testing holds particular significance due to the potential impact on fertility and pregnancy. These antibodies can cross the placenta and may affect the baby's thyroid function. Your healthcare provider may recommend TRAb monitoring before and during pregnancy if you have a history of Graves' disease.
Your healthcare provider may recommend TRAb testing when Graves' disease is suspected, to differentiate between causes of hyperthyroidism, to assess relapse risk after completing antithyroid medication, or during pregnancy when there is a history of Graves' disease. Timing of testing may depend on your specific clinical situation.
While lifestyle measures alone may not directly reduce TRAb levels, some people find that stress management, adequate sleep, a balanced diet, and avoiding smoking may support overall thyroid health. Selenium supplementation has been studied in relation to Graves' eye disease. Always consult your healthcare provider before starting supplements or making significant changes.
This marker is included in the following test panels.
TSH, Free T4, Free T3, and TSH Receptor Antibodies to help assess Graves' disease.